Grace Therapeutics, Inc. Increase (Decrease) in Inventories
Grace Therapeutics, Inc. (GRCE) reported Increase (Decrease) in Inventories of $14.00 thousand for the 3-month period ending 2020-12-31, per its 10-Q filed 2022-02-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2022-02-14
- Grace Therapeutics, Inc. increase (decrease) in inventories for the quarter ending 2020-12-31 was $14.00K.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 9 month |
|---|---|---|
| 2020-12-31 | $14.00K 10-Q · filed 2022-02-14 | $14.00K 10-Q · filed 2022-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |